Robert Shepherd is a highly experienced professional in the field of human therapeutics. With a background in basic research, he has led numerous multidisciplinary teams in the development of various therapeutic products. He holds a PhD in molecular biology and immunology from Monash University and a Certificate in Commercialisation of Science and Technology. Additionally, he holds a BSc in genetics and molecular biology, a diploma in biotechnology, and a BSc (Hons) in developmental genetics, all from Monash University.

Robert's expertise lies in research and development, drug development, and business development. He has held several leadership positions including Research and Development Director and Head of Drug Development at Dimerix Limited, and Senior Drug Development Manager and Drug Development Manager at Medicines Development For Global Health. He has also served as a Communications Advisor at the Australian Society of Plant Scientists and as Business Analyst at Monash University.

Robert is highly skilled in leading teams and managing complex projects. He has extensive experience in collaborating with scientists, regulatory agencies, and business partners, both local and international. His broad experience and expertise make him a valuable asset to any organization in the field of human therapeutics.